AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · IEX Real-Time Price · USD
9.34
-0.02 (-0.21%)
Apr 19, 2024, 4:00 PM EDT - Market closed
AdaptHealth Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for AdaptHealth stock have an average target of 12.98, with a low estimate of 6.50 and a high estimate of 21. The average target predicts an increase of 38.97% from the current stock price of 9.34.
Analyst Consensus: Buy
* Price targets were last updated on Mar 4, 2024.
Analyst Ratings
The average analyst rating for AdaptHealth stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $13 | Buy | Reiterates | $13 | +39.19% | Mar 4, 2024 |
| UBS | UBS | Strong Buy Maintains $9 → $13 | Strong Buy | Maintains | $9 → $13 | +39.19% | Feb 28, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $11 → $13 | Strong Buy | Maintains | $11 → $13 | +39.19% | Feb 28, 2024 |
| UBS | UBS | Strong Buy Maintains $10 → $9 | Strong Buy | Maintains | $10 → $9 | -3.64% | Jan 29, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $18 → $13 | Buy | Maintains | $18 → $13 | +39.19% | Nov 8, 2023 |
Financial Forecast
Revenue This Year
3.38B
from 3.20B
Increased by 5.71%
Revenue Next Year
3.59B
from 3.38B
Increased by 6.09%
EPS This Year
0.81
from -5.31
EPS Next Year
1.05
from 0.81
Increased by 29.16%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.5B | 3.8B | 4.4B |
| Avg | 3.4B | 3.6B | 3.9B |
| Low | 3.2B | 3.4B | 3.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 10.0% | 13.7% | 21.6% |
| Avg | 5.7% | 6.1% | 8.2% |
| Low | 1.1% | -0.1% | -1.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.98 | 1.38 | 1.86 |
| Avg | 0.81 | 1.05 | 1.34 |
| Low | 0.50 | 0.66 | 0.99 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 68.9% | 76.7% |
| Avg | - | 29.2% | 27.3% |
| Low | - | -19.4% | -5.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.